nodes	percent_of_prediction	percent_of_DWPC	metapath
Nepafenac—PTGS1—malignant glioma	0.605	0.636	CbGaD
Nepafenac—PTGS2—malignant glioma	0.346	0.364	CbGaD
Nepafenac—Teratogenicity—Carmustine—malignant glioma	0.00381	0.199	CcSEcCtD
Nepafenac—Conjunctival oedema—Carmustine—malignant glioma	0.00287	0.15	CcSEcCtD
Nepafenac—Impaired healing—Carmustine—malignant glioma	0.00184	0.0964	CcSEcCtD
Nepafenac—Visual acuity reduced—Temozolomide—malignant glioma	0.0013	0.0677	CcSEcCtD
Nepafenac—PTGS2—S1P1 pathway—SPHK1—malignant glioma	0.000768	0.0375	CbGpPWpGaD
Nepafenac—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS1—malignant glioma	0.000728	0.0355	CbGpPWpGaD
Nepafenac—Dry eye—Temozolomide—malignant glioma	0.000712	0.0372	CcSEcCtD
Nepafenac—Diabetes mellitus—Carmustine—malignant glioma	0.000666	0.0348	CcSEcCtD
Nepafenac—Ketorolac—PTGS1—malignant glioma	0.00065	0.0696	CrCbGaD
Nepafenac—PTGS2—C-MYB transcription factor network—YEATS4—malignant glioma	0.000646	0.0315	CbGpPWpGaD
Nepafenac—Eye pain—Carmustine—malignant glioma	0.000641	0.0335	CcSEcCtD
Nepafenac—Bromfenac—PTGS1—malignant glioma	0.000623	0.0667	CrCbGaD
Nepafenac—Eye pain—Temozolomide—malignant glioma	0.00062	0.0324	CcSEcCtD
Nepafenac—PTGS2—Overview of nanoparticle effects—PTGS1—malignant glioma	0.00057	0.0278	CbGpPWpGaD
Nepafenac—Tiaprofenic acid—PTGS1—malignant glioma	0.00053	0.0567	CrCbGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—PTK2—malignant glioma	0.0005	0.0244	CbGpPWpGaD
Nepafenac—Magnesium salicylate—PTGS1—malignant glioma	0.000493	0.0527	CrCbGaD
Nepafenac—Fenbufen—PTGS1—malignant glioma	0.000482	0.0516	CrCbGaD
Nepafenac—PTGS2—Eicosanoid Synthesis—PTGS1—malignant glioma	0.000473	0.0231	CbGpPWpGaD
Nepafenac—Diclofenac—CYP2C18—malignant glioma	0.000472	0.0505	CrCbGaD
Nepafenac—Diclofenac—CXCL8—malignant glioma	0.000452	0.0484	CrCbGaD
Nepafenac—PTGS2—Spinal Cord Injury—ROS1—malignant glioma	0.000439	0.0214	CbGpPWpGaD
Nepafenac—Salsalate—PTGS1—malignant glioma	0.000419	0.0448	CrCbGaD
Nepafenac—Sinusitis—Temozolomide—malignant glioma	0.000404	0.0211	CcSEcCtD
Nepafenac—Ketoprofen—CXCL8—malignant glioma	0.0004	0.0428	CrCbGaD
Nepafenac—PTGS2—Overview of nanoparticle effects—PTK2—malignant glioma	0.000397	0.0194	CbGpPWpGaD
Nepafenac—PTGS2—Prostaglandin Synthesis and Regulation—PTGS1—malignant glioma	0.000396	0.0193	CbGpPWpGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—FN1—malignant glioma	0.000379	0.0185	CbGpPWpGaD
Nepafenac—Eye disorder—Carmustine—malignant glioma	0.000374	0.0196	CcSEcCtD
Nepafenac—Ketorolac—PTGS2—malignant glioma	0.000372	0.0398	CrCbGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—NF1—malignant glioma	0.000371	0.0181	CbGpPWpGaD
Nepafenac—Eye disorder—Temozolomide—malignant glioma	0.000362	0.0189	CcSEcCtD
Nepafenac—Bromfenac—PTGS2—malignant glioma	0.000356	0.0381	CrCbGaD
Nepafenac—PTGS1—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000353	0.0172	CbGpPWpGaD
Nepafenac—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—malignant glioma	0.000352	0.0172	CbGpPWpGaD
Nepafenac—Angiopathy—Temozolomide—malignant glioma	0.000351	0.0184	CcSEcCtD
Nepafenac—Diclofenac—CYP2B6—malignant glioma	0.000351	0.0375	CrCbGaD
Nepafenac—Immune system disorder—Temozolomide—malignant glioma	0.00035	0.0183	CcSEcCtD
Nepafenac—Fenoprofen—PTGS1—malignant glioma	0.000346	0.037	CrCbGaD
Nepafenac—PTGS2—S1P1 pathway—PDGFB—malignant glioma	0.000334	0.0163	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—PIM1—malignant glioma	0.000331	0.0161	CbGpPWpGaD
Nepafenac—Modafinil—CYP2B6—malignant glioma	0.00033	0.0353	CrCbGaD
Nepafenac—Vision blurred—Carmustine—malignant glioma	0.000329	0.0172	CcSEcCtD
Nepafenac—Mefenamic acid—PTGS1—malignant glioma	0.000321	0.0344	CrCbGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—PIK3CD—malignant glioma	0.000319	0.0156	CbGpPWpGaD
Nepafenac—Vision blurred—Temozolomide—malignant glioma	0.000318	0.0166	CcSEcCtD
Nepafenac—PTGS2—S1P1 pathway—KDR—malignant glioma	0.000313	0.0153	CbGpPWpGaD
Nepafenac—PTGS1—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000306	0.0149	CbGpPWpGaD
Nepafenac—Tiaprofenic acid—PTGS2—malignant glioma	0.000303	0.0324	CrCbGaD
Nepafenac—Hypertension—Carmustine—malignant glioma	0.000301	0.0157	CcSEcCtD
Nepafenac—PTGS2—Overview of nanoparticle effects—FN1—malignant glioma	0.000301	0.0147	CbGpPWpGaD
Nepafenac—Carbamazepine—CYP2B6—malignant glioma	0.000301	0.0322	CrCbGaD
Nepafenac—Hypertension—Temozolomide—malignant glioma	0.000291	0.0152	CcSEcCtD
Nepafenac—PTGS1—Overview of nanoparticle effects—BCL2—malignant glioma	0.00029	0.0141	CbGpPWpGaD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000285	0.0149	CcSEcCtD
Nepafenac—Magnesium salicylate—PTGS2—malignant glioma	0.000282	0.0301	CrCbGaD
Nepafenac—Modafinil—SLC6A3—malignant glioma	0.000281	0.0301	CrCbGaD
Nepafenac—Dry mouth—Temozolomide—malignant glioma	0.000281	0.0147	CcSEcCtD
Nepafenac—Fenbufen—PTGS2—malignant glioma	0.000276	0.0295	CrCbGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—PTGS2—malignant glioma	0.000275	0.0134	CbGpPWpGaD
Nepafenac—Nervous system disorder—Temozolomide—malignant glioma	0.00027	0.0141	CcSEcCtD
Nepafenac—Skin disorder—Temozolomide—malignant glioma	0.000267	0.014	CcSEcCtD
Nepafenac—PTGS1—Overview of nanoparticle effects—CXCL8—malignant glioma	0.000267	0.013	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—BCAN—malignant glioma	0.000266	0.013	CbGpPWpGaD
Nepafenac—PTGS2—Arachidonic acid metabolism—PTGS1—malignant glioma	0.000263	0.0128	CbGpPWpGaD
Nepafenac—PTGS2—Overview of nanoparticle effects—PIK3CD—malignant glioma	0.000253	0.0124	CbGpPWpGaD
Nepafenac—Gastrointestinal disorder—Carmustine—malignant glioma	0.000246	0.0128	CcSEcCtD
Nepafenac—Salsalate—PTGS2—malignant glioma	0.000239	0.0256	CrCbGaD
Nepafenac—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000237	0.0124	CcSEcCtD
Nepafenac—Diclofenac—PTGS1—malignant glioma	0.000231	0.0247	CrCbGaD
Nepafenac—PTGS2—Overview of nanoparticle effects—BCL2—malignant glioma	0.00023	0.0112	CbGpPWpGaD
Nepafenac—PTGS1—Eicosanoid Synthesis—PTGS2—malignant glioma	0.000228	0.0111	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—MYB—malignant glioma	0.000221	0.0108	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—GDNF—malignant glioma	0.000214	0.0105	CbGpPWpGaD
Nepafenac—PTGS2—Overview of nanoparticle effects—CXCL8—malignant glioma	0.000212	0.0103	CbGpPWpGaD
Nepafenac—Hypersensitivity—Carmustine—malignant glioma	0.00021	0.011	CcSEcCtD
Nepafenac—Ketoprofen—PTGS1—malignant glioma	0.000204	0.0219	CrCbGaD
Nepafenac—Hypersensitivity—Temozolomide—malignant glioma	0.000203	0.0106	CcSEcCtD
Nepafenac—Fenoprofen—PTGS2—malignant glioma	0.000198	0.0212	CrCbGaD
Nepafenac—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—malignant glioma	0.000198	0.00964	CbGpPWpGaD
Nepafenac—Pruritus—Temozolomide—malignant glioma	0.000195	0.0102	CcSEcCtD
Nepafenac—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—malignant glioma	0.000191	0.00932	CbGpPWpGaD
Nepafenac—Dizziness—Carmustine—malignant glioma	0.000188	0.00983	CcSEcCtD
Nepafenac—PTGS1—Biological oxidations—CYP2B6—malignant glioma	0.000188	0.00916	CbGpPWpGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—TNF—malignant glioma	0.000186	0.00907	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—GFAP—malignant glioma	0.000184	0.00899	CbGpPWpGaD
Nepafenac—Mefenamic acid—PTGS2—malignant glioma	0.000184	0.0196	CrCbGaD
Nepafenac—Dizziness—Temozolomide—malignant glioma	0.000182	0.0095	CcSEcCtD
Nepafenac—Vomiting—Carmustine—malignant glioma	0.000181	0.00945	CcSEcCtD
Nepafenac—Headache—Carmustine—malignant glioma	0.000178	0.00932	CcSEcCtD
Nepafenac—Vomiting—Temozolomide—malignant glioma	0.000175	0.00914	CcSEcCtD
Nepafenac—Headache—Temozolomide—malignant glioma	0.000172	0.009	CcSEcCtD
Nepafenac—PTGS2—S1P1 pathway—VEGFA—malignant glioma	0.000172	0.0084	CbGpPWpGaD
Nepafenac—Nausea—Carmustine—malignant glioma	0.000169	0.00883	CcSEcCtD
Nepafenac—PTGS2—Selenium Micronutrient Network—PTGS1—malignant glioma	0.000167	0.00817	CbGpPWpGaD
Nepafenac—Nausea—Temozolomide—malignant glioma	0.000163	0.00854	CcSEcCtD
Nepafenac—PTGS1—Biological oxidations—CYP2C18—malignant glioma	0.000163	0.00794	CbGpPWpGaD
Nepafenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—malignant glioma	0.000163	0.00793	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—LGALS3—malignant glioma	0.000161	0.00786	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—SOD1—malignant glioma	0.00016	0.0078	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.000154	0.0075	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—CAT—malignant glioma	0.000152	0.0074	CbGpPWpGaD
Nepafenac—PTGS2—Overview of nanoparticle effects—TNF—malignant glioma	0.000148	0.0072	CbGpPWpGaD
Nepafenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—malignant glioma	0.000144	0.00705	CbGpPWpGaD
Nepafenac—Diclofenac—PTGS2—malignant glioma	0.000132	0.0141	CrCbGaD
Nepafenac—PTGS1—Biological oxidations—GSTT1—malignant glioma	0.000132	0.00642	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—malignant glioma	0.000128	0.00625	CbGpPWpGaD
Nepafenac—PTGS1—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000127	0.0062	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—SOD1—malignant glioma	0.000127	0.00619	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—CAT—malignant glioma	0.00012	0.00588	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—HES1—malignant glioma	0.000119	0.00579	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—NCOR1—malignant glioma	0.000118	0.00576	CbGpPWpGaD
Nepafenac—Ketoprofen—PTGS2—malignant glioma	0.000117	0.0125	CrCbGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.000117	0.00568	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	0.000111	0.00544	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—F2—malignant glioma	0.000111	0.00543	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.00011	0.00539	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—malignant glioma	0.000105	0.00513	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—GJA1—malignant glioma	0.000104	0.00506	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	9.84e-05	0.0048	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—malignant glioma	9.78e-05	0.00477	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—malignant glioma	9.36e-05	0.00457	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—malignant glioma	9.34e-05	0.00456	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—RTEL1—malignant glioma	9.22e-05	0.0045	CbGpPWpGaD
Nepafenac—PTGS1—Biological oxidations—GSTP1—malignant glioma	9.12e-05	0.00445	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	9e-05	0.00439	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—F2—malignant glioma	8.83e-05	0.00431	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	8.49e-05	0.00414	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—IFNG—malignant glioma	8.43e-05	0.00411	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—PTGS2—malignant glioma	8.08e-05	0.00394	CbGpPWpGaD
Nepafenac—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—malignant glioma	7.98e-05	0.00389	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	7.81e-05	0.00381	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	7.64e-05	0.00373	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—IL1B—malignant glioma	7.52e-05	0.00367	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—RTEL1—malignant glioma	7.32e-05	0.00357	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	7.28e-05	0.00355	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	7.22e-05	0.00352	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—CDKN2A—malignant glioma	7.12e-05	0.00347	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—BCL2—malignant glioma	7.01e-05	0.00342	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	7e-05	0.00342	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—malignant glioma	6.81e-05	0.00332	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—IFNG—malignant glioma	6.69e-05	0.00326	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	6.59e-05	0.00322	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	6.51e-05	0.00318	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	6.45e-05	0.00315	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	6.38e-05	0.00311	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—IL1B—malignant glioma	5.97e-05	0.00291	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	5.86e-05	0.00286	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—TNF—malignant glioma	5.45e-05	0.00266	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—COX8A—malignant glioma	5.3e-05	0.00259	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IFNG—malignant glioma	5.29e-05	0.00258	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	5.24e-05	0.00256	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	5.23e-05	0.00255	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	5.06e-05	0.00247	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—CXCL8—malignant glioma	4.92e-05	0.0024	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—MYC—malignant glioma	4.82e-05	0.00235	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IL1B—malignant glioma	4.72e-05	0.0023	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—CASP3—malignant glioma	4.71e-05	0.0023	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IL2—malignant glioma	4.7e-05	0.00229	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	4.69e-05	0.00229	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	4.54e-05	0.00222	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ASMT—malignant glioma	4.5e-05	0.0022	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	4.49e-05	0.00219	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—KRAS—malignant glioma	4.46e-05	0.00218	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—MMP9—malignant glioma	4.45e-05	0.00217	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	4.4e-05	0.00215	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—TNF—malignant glioma	4.33e-05	0.00211	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—BCAN—malignant glioma	4.24e-05	0.00207	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—COX8A—malignant glioma	4.21e-05	0.00205	CbGpPWpGaD
Nepafenac—PTGS2—Disease—BCAN—malignant glioma	4.01e-05	0.00196	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	3.83e-05	0.00187	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	3.76e-05	0.00183	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—MYC—malignant glioma	3.68e-05	0.00179	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	3.63e-05	0.00177	CbGpPWpGaD
Nepafenac—PTGS2—Disease—DTX1—malignant glioma	3.63e-05	0.00177	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—EGFR—malignant glioma	3.6e-05	0.00175	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	3.58e-05	0.00175	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ASMT—malignant glioma	3.58e-05	0.00174	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	3.57e-05	0.00174	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	3.53e-05	0.00172	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	3.5e-05	0.00171	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—TNF—malignant glioma	3.42e-05	0.00167	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—IDH2—malignant glioma	3.41e-05	0.00167	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—BCAN—malignant glioma	3.36e-05	0.00164	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.22e-05	0.00157	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP2B6—malignant glioma	3.21e-05	0.00157	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	3.2e-05	0.00156	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—TP53—malignant glioma	3.02e-05	0.00147	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	3.01e-05	0.00147	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—IDH1—malignant glioma	2.94e-05	0.00143	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HEY2—malignant glioma	2.85e-05	0.00139	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SPHK1—malignant glioma	2.84e-05	0.00139	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP2C18—malignant glioma	2.78e-05	0.00136	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IDH1—malignant glioma	2.78e-05	0.00136	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	2.72e-05	0.00133	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—IDH2—malignant glioma	2.71e-05	0.00132	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HEY1—malignant glioma	2.64e-05	0.00129	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.62e-05	0.00128	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HIST1H3B—malignant glioma	2.56e-05	0.00125	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.56e-05	0.00125	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP2B6—malignant glioma	2.55e-05	0.00124	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	2.5e-05	0.00122	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	2.45e-05	0.00119	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.39e-05	0.00117	CbGpPWpGaD
Nepafenac—PTGS2—Disease—JAG2—malignant glioma	2.34e-05	0.00114	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—IDH1—malignant glioma	2.33e-05	0.00114	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	2.33e-05	0.00114	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	2.31e-05	0.00113	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.31e-05	0.00113	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SPHK1—malignant glioma	2.26e-05	0.0011	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GSTT1—malignant glioma	2.25e-05	0.0011	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP2C18—malignant glioma	2.21e-05	0.00108	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	2.12e-05	0.00104	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.1e-05	0.00103	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.08e-05	0.00102	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	2.05e-05	0.001	CbGpPWpGaD
Nepafenac—PTGS2—Disease—H3F3A—malignant glioma	1.98e-05	0.000966	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—BCHE—malignant glioma	1.96e-05	0.000957	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SLC5A5—malignant glioma	1.94e-05	0.000945	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.9e-05	0.000926	CbGpPWpGaD
Nepafenac—PTGS2—Disease—JAG1—malignant glioma	1.87e-05	0.000911	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.83e-05	0.000894	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.83e-05	0.000894	CbGpPWpGaD
Nepafenac—PTGS2—Disease—FBXW7—malignant glioma	1.83e-05	0.000892	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.81e-05	0.000886	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GSTT1—malignant glioma	1.79e-05	0.000872	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.73e-05	0.000846	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PTGS1—malignant glioma	1.67e-05	0.000817	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.67e-05	0.000814	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.58e-05	0.000772	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GSTP1—malignant glioma	1.56e-05	0.000761	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—BCHE—malignant glioma	1.56e-05	0.00076	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SLC5A5—malignant glioma	1.54e-05	0.00075	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CAT—malignant glioma	1.52e-05	0.000741	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.45e-05	0.00071	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NCOR1—malignant glioma	1.43e-05	0.0007	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CDKN2B—malignant glioma	1.43e-05	0.000699	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HES1—malignant glioma	1.37e-05	0.000667	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NCOR1—malignant glioma	1.36e-05	0.000663	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PDGFRA—malignant glioma	1.3e-05	0.000635	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.26e-05	0.000613	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GSTP1—malignant glioma	1.24e-05	0.000604	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CAT—malignant glioma	1.21e-05	0.000588	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TERT—malignant glioma	1.2e-05	0.000584	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HLA-A—malignant glioma	1.2e-05	0.000584	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PDGFB—malignant glioma	1.17e-05	0.00057	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CAV1—malignant glioma	1.17e-05	0.00057	CbGpPWpGaD
Nepafenac—PTGS2—Disease—FGFR1—malignant glioma	1.16e-05	0.000567	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HIF1A—malignant glioma	1.15e-05	0.000559	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NCOR1—malignant glioma	1.14e-05	0.000555	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.12e-05	0.000545	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CAV1—malignant glioma	1.11e-05	0.000541	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PIK3CG—malignant glioma	1.06e-05	0.000519	CbGpPWpGaD
Nepafenac—PTGS2—Disease—BAD—malignant glioma	1.04e-05	0.000508	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NOTCH1—malignant glioma	1.03e-05	0.000504	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PPARG—malignant glioma	1.03e-05	0.000501	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CD80—malignant glioma	1.01e-05	0.000493	CbGpPWpGaD
Nepafenac—PTGS2—Disease—APC—malignant glioma	1.01e-05	0.000492	CbGpPWpGaD
Nepafenac—PTGS2—Disease—EGF—malignant glioma	9.98e-06	0.000487	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PTPN11—malignant glioma	9.91e-06	0.000484	CbGpPWpGaD
Nepafenac—PTGS2—Disease—BRAF—malignant glioma	9.49e-06	0.000463	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PIK3CD—malignant glioma	9.36e-06	0.000457	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CAV1—malignant glioma	9.28e-06	0.000453	CbGpPWpGaD
Nepafenac—PTGS2—Disease—AKT2—malignant glioma	9.23e-06	0.000451	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PIK3CD—malignant glioma	8.87e-06	0.000433	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.86e-06	0.000433	CbGpPWpGaD
Nepafenac—PTGS2—Disease—FGF2—malignant glioma	8.49e-06	0.000414	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PIK3CG—malignant glioma	8.45e-06	0.000412	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PIK3CB—malignant glioma	8.16e-06	0.000398	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PPARG—malignant glioma	8.16e-06	0.000398	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PTGS2—malignant glioma	8.08e-06	0.000394	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MDM2—malignant glioma	7.95e-06	0.000388	CbGpPWpGaD
Nepafenac—PTGS2—Disease—RAF1—malignant glioma	7.92e-06	0.000386	CbGpPWpGaD
Nepafenac—PTGS2—Disease—ERBB2—malignant glioma	7.84e-06	0.000382	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PIK3CB—malignant glioma	7.73e-06	0.000377	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PIK3CD—malignant glioma	7.43e-06	0.000363	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PTEN—malignant glioma	7.05e-06	0.000344	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PTEN—malignant glioma	6.68e-06	0.000326	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PIK3CB—malignant glioma	6.48e-06	0.000316	CbGpPWpGaD
Nepafenac—PTGS2—Disease—STAT3—malignant glioma	5.98e-06	0.000292	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PTEN—malignant glioma	5.6e-06	0.000273	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MYC—malignant glioma	5.55e-06	0.000271	CbGpPWpGaD
Nepafenac—PTGS2—Disease—EGFR—malignant glioma	5.43e-06	0.000265	CbGpPWpGaD
Nepafenac—PTGS2—Disease—KRAS—malignant glioma	5.13e-06	0.00025	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PIK3CA—malignant glioma	4.97e-06	0.000243	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PIK3CA—malignant glioma	4.71e-06	0.00023	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—AKT1—malignant glioma	4.06e-06	0.000198	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PIK3CA—malignant glioma	3.95e-06	0.000193	CbGpPWpGaD
Nepafenac—PTGS2—Disease—AKT1—malignant glioma	3.85e-06	0.000188	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—AKT1—malignant glioma	3.22e-06	0.000157	CbGpPWpGaD
